Literature DB >> 21455661

Morphological and functional analyses of two infants with obstructive renal dysplasia.

Kenichiro Miura1, Takashi Sekine, Riki Nishimura, Yutaka Kanamori, Atsuhiro Yanagisawa, Kiyohide Sakai, Michio Nagata, Takashi Igarashi.   

Abstract

Renal dysplasia associated with urinary tract obstruction comprises two distinct phenotypes, i.e., multicystic dysplastic kidney (MCDK) and obstructive renal dysplasia (ORD). MCDK is a common manifestation in infants with renal dysplasia, which is characterized by multiloculated thin-walled cysts with no functional parenchyma and an atretic ureter owing to pyelocalyceal occlusion early in fetal life. In contrast, ORD is an extremely rare condition which is caused by severe obstruction of the distal ureter or urethra. Here, we report two infants with ORD. Both patients manifested unilateral kidney enlargement with multiple cortical cysts, mild hydronephrosis, and marked dilatation of the ipsilateral ureter. Contralateral kidneys and urinary tracts revealed no apparent radiological abnormalities. Serial ultrasonographic studies of fetal and neonatal kidneys in both cases revealed that ureteral dilatation was evident at gestational week 16 and 27, respectively, and most of the cortical cysts disappeared within 1-3 months after birth. The functions of the affected kidneys were severely impaired but evident at the time of birth. These manifestations were consistent with a diagnosis of ORD, and were distinct from the features of MCDK. Our observation of fetal and infantile kidneys in these two cases provides us with a better understanding of the pathogenesis of ORD.

Entities:  

Mesh:

Year:  2011        PMID: 21455661     DOI: 10.1007/s10157-011-0429-x

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  10 in total

1.  Prune-belly syndrome diagnosed at 14 weeks' gestation with severe urethral obstruction but normal kidneys.

Authors:  M Shigeta; M Nagata; H Shimoyamada; S Shibata; S Okuno; H Hamada; T Watanabe
Journal:  Pediatr Nephrol       Date:  1999-02       Impact factor: 3.714

Review 2.  Congential obstructive nephropathy gets complicated.

Authors:  Adrian S Woolf
Journal:  Kidney Int       Date:  2003-02       Impact factor: 10.612

3.  Initial pathological events in renal dysplasia with urinary tract obstruction in utero.

Authors:  S Shibata; M Shigeta; Y Shu; T Watanabe; M Nagata
Journal:  Virchows Arch       Date:  2001-10       Impact factor: 4.064

Review 4.  Pathogenesis of dysplastic kidney associated with urinary tract obstruction in utero.

Authors:  Michio Nagata; Sawako Shibata; Yujin Shu
Journal:  Nephrol Dial Transplant       Date:  2002       Impact factor: 5.992

5.  Sequential invasive assessment of fetal renal function and the intrauterine treatment of fetal obstructive uropathies.

Authors:  M I Evans; A J Sacks; M P Johnson; A G Robichaux; M May; K S Moghissi
Journal:  Obstet Gynecol       Date:  1991-04       Impact factor: 7.661

6.  Vesicoamniotic shunt for complete urinary tract obstruction is partially effective.

Authors:  Hiroaki Kitagawa; Kevin C Pringle; Junki Koike; Jane Zuccollo; Yasuji Seki; Munechika Wakisaka; Yuriko Sato; Hideaki Sato; Hideki Nagae; Koonosuke Nakada
Journal:  J Pediatr Surg       Date:  2006-02       Impact factor: 2.545

7.  Etiology of prune belly syndrome: evidence of megalocystic origin in an early fetus.

Authors:  S Terada; N Suzuki; K Uchide; H Ueno; K Akasofu
Journal:  Obstet Gynecol       Date:  1994-05       Impact factor: 7.661

8.  A 10 year audit of antenatal ultrasound detection of renal disease.

Authors:  E Dillon; A Ryall
Journal:  Br J Radiol       Date:  1998-05       Impact factor: 3.039

Review 9.  Renal cystic diseases: a review.

Authors:  Michele Bisceglia; Carlos A Galliani; Christof Senger; Carmine Stallone; Adalberto Sessa
Journal:  Adv Anat Pathol       Date:  2006-01       Impact factor: 3.875

Review 10.  Congenital nephropathies and uropathies.

Authors:  N Becker; E D Avner
Journal:  Pediatr Clin North Am       Date:  1995-12       Impact factor: 3.278

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.